Overall Survival Following Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy in Clinically Node Negative T1 Triple Negative Breast Cancer.

Huang, Kai; Jakub, James; Gabriel, Emmanuel; Moreno-Aspitia, Alvaro; McLaughlin, Sarah

Huang, Kai; Jakub, James; Gabriel, Emmanuel; Moreno-Aspitia, Alvaro; McLaughlin, Sarah.

Afiliação

Huang K; Department of Surgery, University of Iowa Hospitals and Clinics, Iowa City, IA, USA.
Jakub J; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
Gabriel E; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL, USA.
Moreno-Aspitia A; Jacoby Center for Breast Health, Division of Hematology Oncology, Mayo Clinic Florida, Jacksonville, FL, USA.
McLaughlin S; Department of Surgery, Mayo Clinic Florida, Jacksonville, FL, USA. McLaughlin.Sarah@mayo.edu.

Ann Surg Oncol ; 30(12): 7026-7035, 2023 Nov.

Article em En | MEDLINE | ID: mdl-37490162

Assuntos

Terapia Neoadjuvante; Neoplasias de Mama Triplo Negativas; Humanos; Feminino; Neoplasias de Mama Triplo Negativas/tratamento farmacológico; Estudos Retrospectivos; Quimioterapia Adjuvante; Modelos de Riscos Proporcionais; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Terapia Neoadjuvante / Neoplasias de Mama Triplo Negativas Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google